Literature DB >> 30291572

What Are We Missing in the Diagnostic Criteria for Migraine?

Amanda Tinsley1, John Farr Rothrock2.   

Abstract

PURPOSE OF REVIEW: This review is intended to examine how the diagnostic criteria for migraine have evolved over the past 45 years and to evaluate the strengths and weaknesses of the current diagnostic criteria promulgated by the International Classification of Headache Disorders (ICHD). RECENT
FINDINGS: The ICHD is a comprehensive and systematic classification system for headache disorders. As the pathophysiology of migraine is more fully elucidated and more sophisticated diagnostic technologies are developed (e.g., the identification of biomarkers), the current diagnostic criteria for migraine will likely be further refined. The ICHD has allowed for more precise research study design in the field of headache medicine. The current diagnostic criteria for migraine outlined in the 3rd version of the ICHD are far more sensitive and specific than the clinical criteria proposed in 1962. In future iterations, dividing episodic and chronic migraine into subtypes based on frequency (i.e., low frequency vs high frequency; near-daily vs daily) potentially could assist in guiding clinical management. In addition, a better understanding of aura, vestibular migraine, migrainous infarction, and hemiplegic migraine likely will lead to more refined diagnostic criteria for those entities.

Entities:  

Keywords:  Aura; International Classification of Headache Disorders; Migraine

Mesh:

Year:  2018        PMID: 30291572     DOI: 10.1007/s11916-018-0733-1

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  17 in total

1.  Responsiveness of non-IHS migraine and tension-type headache to sumatriptan.

Authors:  R K Cady; D Gutterman; J A Saiers; M E Beach
Journal:  Cephalalgia       Date:  1997-08       Impact factor: 6.292

2.  Cerebrospinal fluid analyses in migraine patients and controls.

Authors:  J F Rothrock; K R Mar; T L Yaksh; A Golbeck; A C Moore
Journal:  Cephalalgia       Date:  1995-12       Impact factor: 6.292

3.  No increase of calcitonin gene-related peptide in jugular blood during migraine.

Authors:  Jesper Filtenborg Tvedskov; Kerstin Lipka; Messoud Ashina; Helle K Iversen; Søren Schifter; Jes Olesen
Journal:  Ann Neurol       Date:  2005-10       Impact factor: 10.422

4.  2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study.

Authors:  R B Lipton; W F Stewart; R Cady; C Hall; S O'Quinn; T Kuhn; D Gutterman
Journal:  Headache       Date:  2000 Nov-Dec       Impact factor: 5.887

Review 5.  Neurobiology in primary headaches.

Authors:  Lars Edvinsson; Rolf Uddman
Journal:  Brain Res Brain Res Rev       Date:  2004-11-18

6.  Demographic and clinical characteristics of patients with episodic migraine versus chronic daily headache.

Authors:  J Rothrock; M Patel; P Lyden; C Jackson
Journal:  Cephalalgia       Date:  1996-02       Impact factor: 6.292

7.  Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally.

Authors:  V Gallai; P Sarchielli; A Floridi; M Franceschini; M Codini; G Glioti; A Trequattrini; R Palumbo
Journal:  Cephalalgia       Date:  1995-10       Impact factor: 6.292

8.  Neuronal Dysexcitability May Be a Biomarker of Migraine: A Visual Evoked Potential Study.

Authors:  Jayantee Kalita; Ravi Uniyal; Usha K Misra; Sanjeev K Bhoi
Journal:  Clin EEG Neurosci       Date:  2017-10-03       Impact factor: 1.843

9.  A differential response to treatment with divalproex sodium in patients with intractable headache.

Authors:  J F Rothrock; N M Kelly; M L Brody; A Golbeck
Journal:  Cephalalgia       Date:  1994-06       Impact factor: 6.292

10.  Lipidomic analysis of serum samples from migraine patients.

Authors:  Caixia Ren; Jia Liu; Juntuo Zhou; Hui Liang; Yayun Wang; Yinping Sun; Bin Ma; Yuxin Yin
Journal:  Lipids Health Dis       Date:  2018-02-02       Impact factor: 3.876

View more
  4 in total

Review 1.  Migraine and Cochlear Symptoms.

Authors:  Xin Ma; Yu-Jie Ke; Yuan-Yuan Jing; Tong-Xiang Diao; Li-Sheng Yu
Journal:  Curr Med Sci       Date:  2021-08-17

2.  Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine - an updated systematic review and meta-analysis.

Authors:  Hong Deng; Gai-Gai Li; Hao Nie; Yang-Yang Feng; Guang-Yu Guo; Wen-Liang Guo; Zhou-Ping Tang
Journal:  BMC Neurol       Date:  2020-02-15       Impact factor: 2.474

3.  Daily Headache in Chronic Migraine Is a Predictive Factor of Response in Patients Who Had Completed Three Sessions of OnabotulinumtoxinA.

Authors:  Enrique Martínez-Pías; Ángel L Guerrero; Álvaro Sierra; Javier Trigo; David García-Azorín
Journal:  Toxins (Basel)       Date:  2021-06-21       Impact factor: 4.546

4.  Validation of an algorithm for automated classification of migraine and tension-type headache attacks in an electronic headache diary.

Authors:  Aaron Roesch; Markus A Dahlem; Lars Neeb; Tobias Kurth
Journal:  J Headache Pain       Date:  2020-06-12       Impact factor: 7.277

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.